Advances in targeted therapy in gynaecological cancers
PARP inhibitors in ovarian cancer: What are the next steps?
Date
10 Oct 2016Session
Advances in targeted therapy in gynaecological cancersPresenters
Jonathan LedermannAuthors
J.A. LedermannAuthor affiliations
- Cancer Research Uk And Ucl Cancer Trials Centre, University College London Cancer Institute, WC1E6BT - London/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Cervical cancer therapy in 2016
Presenter: Mansoor Raza Mirza
Session: Advances in targeted therapy in gynaecological cancers
Resources:
Slides